• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:林茂,刘敏惠,陈崇泽,戴亨纷.1120例药品不良反应/事件的发生特点与转归分析[J].药学研究,2022,41(2):136-140[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2521次   下载 2281次 本文二维码信息
码上扫一扫!
1120例药品不良反应/事件的发生特点与转归分析
林茂1,刘敏惠1,陈崇泽1,戴亨纷2
字体:加大+|默认|缩小-
(1.福州市长乐区医院药学部,福建 福州 350200;2.福建医科大学附属福州市第一医院药学部,福建 福州 350009)
摘要:
目的 调查我院药品不良反应/事件发生情况,分析其发生特点和转归,为临床安全、合理用药提供参考。方法 对我院2018年至2019年上报至国家不良反应监测中心的1 120例ADR/ADE报告进行回顾性分析,探索ADR/ADE与年龄、性别、体重、药品种类、给药途径的相关性。结果 在1 120例ADR/ADE报告中,新的和严重的报告数共989例(88.30%),已知的ADR/ADE损害较严重;发生严重ADR/ADE的比例与性别、体重无显著相关(P>0.05),而与年龄显著相关(P<0.05),严重ADR/ADE患者年龄较大;给药途径以口服(624例,占55.71%)和静脉滴注(374例,占33.39%)为主,口服引起的严重ADR/ADE比例较高;报告数最多的药品种类是抗感染药物(298例,占26.61%),严重ADR/ADE占比最高的是内分泌系统用药(共143例,严重132例,占92.31%);涉及的器官/系统报告数排前三名分别是代谢及营养疾病(249例,占22.23%)、肝胆疾病(178例,占15.89%)和血管,出血及凝血疾病(170例,占15.18%);999例转归结果为痊愈或好转,63例未好转,不同处置方式对ADR/ADE好转率无差异(P>0.05),与未处理者存在显著差异(P<0.05);潜伏期中位数7天,恢复期1天。结论 应加强对老年人的用药监测,特别是口服药安全问题应引起更多重视,医务人员应熟悉已知的ADR/ADE,以期早发现并及时处理,避免严重不良反应/事件发生。
关键词:  药品不良反应/事件  转归  潜伏期
DOI:10.13506/j.cnki.jpr.2022.02.015
基金项目:
出版日期:2022-02-25
Retrospective analysis of 1120 adverse drug reactions/events
LIN Mao1,LIU Minhui1,CHEN Chongze1,DAI Hengfen2
(1.Department of Pharmacy, Changle District Hospital of Fuzhou, Fujian Fuzhou 350200, China; 2.Department of Pharmacy, Affiliated Fuzhou First Hospital of Fujian Medical University,Fujian Fuzhou 350009, China)
Abstract:
Objective To investigate the occurrence of adverse drug reactions/events in a hospital and analyze their characteristics and outcomes, so as to provide reference for clinical safe and rational drug use. Methods A retrospective analysis was performed on 1120 ADR/ADE reports uploaded to National Center for ADR Monitoring from 2018 to 2019 in our hospital,to explore the correlation between ADR/ADE and age, gender, weight, drug type, and route of administration. Results Among the 1120 ADR/ADE reports, the number of new and serious reports was 989 (88.30%),known type of ADR/ADE damage is more serious. The proportion of severe ADR/ADE is not significantly related to gender and weight (P>0.05), but is significantly related to age (P<0.05), patients with severe ADR/ADE are older; The main routes of administration are oral (624, 55.71%) and intravenous drip (374, 33.39%). The proportion of severe ADR/ADE caused by oral administration is relatively high; The most reported type of drug is anti-infective drugs (298, 26.61%), and the drug with the highest ratio of severe ADR/ADE is endocrine system drugs (143 cases in total, 132 severe cases, 92.31%); The top three reported organs/systems involved are metabolic and nutritional disorders (249, 22.23%), liver and biliary disorders (178, 15.89%), and vascular, bleeding and clotting disorders (170, 15.18%).The outcome of 999 cases was cured or improved, and 63 cases did not improve. There was no difference in the improvement rate of ADR/ADE with different treatment methods (P>0.05), which was significantly different from that of untreated patients (P<0.05); The median incubation period is 7 days, and the recovery period is 1 day.Conclusion The monitoring of medications for the elderly should be strengthened, and more attention should be paid to the safety of oral medications. Medical staff should be familiar with the known ADR/ADE in order to detect them early and deal with them in time to avoid serious adverse reactions/events.
Key words:  Adverse drug reactions/events  Outcome  Incubation period
今日访问量:2340    总访问量:55338713
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司